AKT1 and neoplasm: We therefore suggest that the inhibition of pro-TGF-α shedding in irradiated tumor cells treated with MEK inhibition results in the reduction in soluble TGF-α, in turn resulting in the downregulation of the PI3K/AKT pathway.